Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 23 December

Jessica Amir
December 23, 2020

Morning Bell 22 December

Jessica Amir
December 22, 2020

Morning Bell 21 December

Jessica Amir
December 21, 2020

Weekly Wrap 18 December

Jessica Amir
December 18, 2020

Morning Bell 18 December

Jessica Amir
December 18, 2020

Morning Bell 17 December

Jessica Amir
December 17, 2020

Morning Bell 16 December

Jessica Amir
December 16, 2020

Morning Bell 15 December

Jessica Amir
December 15, 2020

Morning Bell 14 December

Jessica Amir
December 14, 2020

Weekly Wrap 11 December

Jessica Amir
December 11, 2020